These days, investors have many more options beyond traditional cap-weighted exchange traded funds, or those funds that assign weights to holdings based on market value.
That is one way of doing things and it is a methodology that ETF sponsors have used for years, but investors have also been embracing alternative weighting methodologies.
While cap-weighted ETFs often provided investors with the lowest fees, some funds that are constructed on fundamental factors are worthy of consideration as well. That is the case because there are plenty of examples where fundamental screening can result in superior returns for investors.
Or investors can merely say that fundamentals are an integral part of the stock picking process and acknowledge that what works at the single stock level can certainly be efficacious with ETFs. With that in mind, here are some ETFs built on fundamental factors, not cap-weighting, that may not be getting the appreciation they deserve.
First Trust Europe AlphaDEX Fund (NYSEARCA:FEP) Monday's negativity serves as a reminder that all is still not well in Europe, particularly in the peripheral countries such as Italy and Spain. It cannot be forgotten that factors such as the banking system, public policy and household capacity could weigh on or be catalysts for European equities over the next two years.
No, Europe is not sanguine as global investors had previously hoped, but FEP's methodology may help investors skirt some European risk. FEP's constituents are ranked on growth factors such as sales to price and one year sales growth and value factors such as cash flow to price and return on assets.
FEP, which will turn two years old in April, avoids single-stock risk by allocating just 1.15 percent to its largest holding and the fund is not heavy on PIIGS stocks.
The U.K. accounts for 26 percent of FEP's weight while Sweden and Norway combine for almost 11 percent, indicating there is significant non-Eurozone exposure in the fund. FEP is up 12 percent in the past year, but still offers a play on attractive European equity valuations with a P/E ratio of 11.81 and a price-to-book ratio of 1.15.
The iShares S&P Europe 350 Index Fund (NYSEARCA:IEV) has a P/E of almost 17 and a price-to-book of nearly three.
PowerShares FTSE RAFI Emerging Markets Portfolio (NYSEARCA:PXH) Just as FEP faces intense competition in the market for diversified Europe ETFs, the PowerShares FTSE RAFI Emerging Markets Portfolio deals with the same situation among multi-country emerging markets ETFs.
With almost $388 million in assets under management and average daily volume of nearly 115,000 shares, calling PXH anonymous "obscure" is not accurate, but it is fair to say the ETF is not as well known as some diversified emerging markets funds.
Components for PXH are selected based on book value, cash flow, sales and dividends and weighted based on a fundamental score. That methodology can work in the right environment as PXH has returned about 8.4 percent over the past six months, but investors do need to do some homework before jumping in.
Since dividends are part of PXH's screening methodology, that means the ETF will almost certainly have large allocations to Taiwan and Brazil, two of the developing nations with solid dividend reputations. Not surprisingly, those two countries account for nearly 35 percent of the fund's weight.
Combine the dividend factor with the cash flow and book value screens and it would also be reasonable to expect Russia to loom large in this fund. That is the case because the government there has forced state-controlled enterprises to boost dividends.
Additionally, Russian firms have a reputation for being quite profitable, but also for trading at discounts to peers in other developing markets.
Bottom line: Russia accounts for over 11 percent of PXH's weight and two Russian stocks - Gazprom and Lukoil - are the ETF's top two holdings.
For more on ETFs, click here.
Disclaimer: Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.